John K Bell - Net Worth and Insider Trading
John K Bell Net Worth
The estimated net worth of John K Bell is at least $196 dollars as of 2024-11-13. John K Bell is the Director of Kintara Therapeutics Inc and owns about 26 shares of Kintara Therapeutics Inc (KTRA) stock worth over $196. Details can be seen in John K Bell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John K Bell has not made any transactions after 2019-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John K Bell
John K Bell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John K Bell owns 2 companies in total, including Kintara Therapeutics Inc (KTRA) , and Avenir Wellness Solutions Inc (AVRW) .
Click here to see the complete history of John K Bell’s form 4 insider trades.
Insider Ownership Summary of John K Bell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KTRA | Kintara Therapeutics Inc | 2019-09-13 | director |
AVRW | Avenir Wellness Solutions Inc | 2019-11-18 | director |
John K Bell Latest Holdings Summary
John K Bell currently owns a total of 1 stock. John K Bell owns 26 shares of Kintara Therapeutics Inc (KTRA) as of September 13, 2019, with a value of $196.
Latest Holdings of John K Bell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KTRA | Kintara Therapeutics Inc | 2019-09-13 | 26 | 7.54 | 196 |
Holding Weightings of John K Bell
John K Bell Form 4 Trading Tracker
According to the SEC Form 4 filings, John K Bell has made a total of 0 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 20 shares on September 13, 2019, which cost John K Bell around $23,800.
Insider Trading History of John K Bell
- 1
John K Bell Trading Performance
GuruFocus tracks the stock performance after each of John K Bell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John K Bell is -20.39%. GuruFocus also compares John K Bell's trading performance to market benchmark return within the same time period. The performance of stocks bought by John K Bell within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John K Bell's insider trading performs compared to the benchmark.
Performance of John K Bell
John K Bell Ownership Network
Ownership Network List of John K Bell
Ownership Network Relation of John K Bell
John K Bell Owned Company Details
What does Kintara Therapeutics Inc do?
Who are the key executives at Kintara Therapeutics Inc?
John K Bell is the director of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and director & Head of Strategic Partnerships Saiid Zarrabian .
Kintara Therapeutics Inc (KTRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kintara Therapeutics Inc Insider Transactions
John K Bell Mailing Address
Above is the net worth, insider trading, and ownership report for John K Bell. You might contact John K Bell via mailing address: 38 Fallbrook Lane Rr 33, Cambridge A6 N3h 4r8.